98%
921
2 minutes
20
N 6-methyladenosine (m6A) is the most prevalent RNA epigenetic modification in eukaryotes, catalyzed by methyltransferases (writers), removed by demethylases (erasers), and recognized by binding proteins (readers). While previous studies have established the essential role of m6A homeostasis in regulating fruit ripening, the post-transcriptional mechanisms underlying m6A-mediated quality trait formation remain poorly understood. Following our recent discovery of a YT521B homology (YTH) domain-containing m6A reader gene, SlYTH2, as a translational repressor for the production of tomato (Solanum lycopersicum) aroma volatiles, we reveal here a distinct regulatory effect through knockout of SlYTH1, which specifically reduces flavor-related volatiles in tomato fruit without affecting the days from anthesis to fruit color break, ethylene production, or firmness. Notably, this finding contrasts with the role of SlYTH2, which negatively regulates fruit aroma, highlighting the opposing effects of SlYTH1 and SlYTH2 in modulating fruit aroma. Mechanistically, SlYTH1 binds to m6A-modified mRNA targets both in vitro and in vivo, performing dual roles in maintaining mRNA stability and promoting translation. Specifically, the loss of SlYTH1 function accelerated the decline in the transcript and protein levels of 2 key targets, SlBCAT1 and SlTNH1, which are essential for volatile biosynthesis. This study provides insights into the role of m6A modification in regulating fruit flavor quality during ripening. Furthermore, it identifies SlYTH1 as a potential genetic target for improving fruit flavor without altering the timing of ripening.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/plphys/kiaf245 | DOI Listing |
J Immunother Cancer
September 2025
Department of Biochemistry and Molecular Genetics, The University of Alabama at Birmingham, Birmingham, Alabama, USA
RNA molecules are subject to extensive post-transcriptional modifications that fine-tune their stability, localization, and function. Among the more than 100 known RNA modifications, N6-methyladenosine (mA) is the most abundant internal mark on eukaryotic messenger RNAs. This dynamic modification is installed by methyltransferases ("writers"), removed by demethylases ("erasers"), and interpreted by RNA-binding proteins ("readers") to modulate gene expression.
View Article and Find Full Text PDFMol Med
September 2025
Department of the Second Cadre Ward, General Hospital of Northern Theater Command, Shenyang, China.
Background: Neuroinflammation mediated by microglia activation is the key pathological mechanisms for cerebral ischemia-reperfusion injury (CIRI). This study investigated the role and underlying molecular mechanism of Rhomboid 5 homolog 2 (RHBDF2) in neuroinflammation during CIRI.
Methods: The in vivo middle cerebral artery occlusion and reperfusion (MCAO/R) mouse model and in vitro HMC3 microglia subjected to oxygen glucose deprivation and reperfusion (OGD/R) were established to mimic CIRI.
PeerJ
September 2025
Changzhou Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing University of Traditional Chinese Medicine, Changzhou, China.
Background: Kidney disease is a major global health issue, causing numerous deaths and a loss of life years. This prompts us to explore potential targets or mechanisms that may increase the likelihood of diagnosing and treating kidney diseases. N6-methyladenosine (mA) modifications dynamically regulate RNA through "writer" enzymes, "eraser" enzymes, and "reader" proteins, influencing its processing, stability, and translation efficiency.
View Article and Find Full Text PDFbioRxiv
August 2025
Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School Boston, MA, USA.
N6-methyladenosine (m6A) is the most prevalent internal mRNA modification, enriched in the CNS yet poorly characterized in glioma. Using long-read RNA sequencing, we mapped m6A in an glioma model following knockdown (KD) of the reader IGF2BP2, writer METTL3, and eraser ALKBH5, with naive glioma cells and astrocytes as controls. Glioma cells exhibited a two-fold reduction in global m6A, suggesting progressive loss from healthy to malignant states.
View Article and Find Full Text PDFmedRxiv
August 2025
Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Gliomas are biologically heterogeneous brain tumors with marked differences in clinical behavior based on the IDH1 mutation status. While epigenetic dysregulation is well characterized, the contribution of RNA modifications, particularly N6-methyladenosine (m6A), remains underexplored. Using direct RNA nanopore sequencing of patient-derived gliomas, we generated the first isoform-resolved m6A maps across IDH1-mutant and wild-type tumors.
View Article and Find Full Text PDF